U.S. flag

An official website of the United States government

NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 21, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002512605.3

Allele description [Variation Report for NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp)]

NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp)

Gene:
ALDOB:aldolase, fructose-bisphosphate B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q31.1
Genomic location:
Preferred name:
NM_000035.4(ALDOB):c.524C>A (p.Ala175Asp)
HGVS:
  • NC_000009.12:g.101427498G>T
  • NG_012387.1:g.13283C>A
  • NM_000035.4:c.524C>AMANE SELECT
  • NP_000026.2:p.Ala175Asp
  • LRG_1244t1:c.524C>A
  • LRG_1244:g.13283C>A
  • LRG_1244p1:p.Ala175Asp
  • NC_000009.11:g.104189780G>T
  • NM_000035.3:c.524C>A
  • NP_000026.2:p.A175D
  • P05062:p.Ala175Asp
Protein change:
A175D; ALA174ASP
Links:
UniProtKB: P05062#VAR_000554; OMIM: 612724.0002; dbSNP: rs76917243
NCBI 1000 Genomes Browser:
rs76917243
Molecular consequence:
  • NM_000035.4:c.524C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003680248Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Apr 21, 2022)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular analysis of aldolase B genes in hereditary fructose intolerance.

Cross NC, de Franchis R, Sebastio G, Dazzo C, Tolan DR, Gregori C, Odievre M, Vidailhet M, Romano V, Mascali G, et al.

Lancet. 1990 Feb 10;335(8685):306-9.

PubMed [citation]
PMID:
1967768

Molecular analysis of the aldolase B gene in patients with hereditary fructose intolerance from Spain.

Sánchez-Gutiérrez JC, Benlloch T, Leal MA, Samper B, García-Ripoll I, Felíu JE.

J Med Genet. 2002 Sep;39(9):e56. No abstract available.

PubMed [citation]
PMID:
12205126
PMCID:
PMC1735221
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV003680248.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The c.524C>A (p.A175D) alteration is located in exon 5 (coding exon 4) of the ALDOB gene. This alteration results from a C to A substitution at nucleotide position 524, causing the alanine (A) at amino acid position 175 to be replaced by an aspartic acid (D). Based on data from gnomAD, the A allele has an overall frequency of 0.04% (99/282292) total alleles studied. The highest observed frequency was 0.16% (17/10362) of Ashkenazi Jewish alleles. This alteration has been reported in multiple unrelated patients with hereditary fructose intolerance and is one of the most common mutations in the U.S. and Europe (Cross, 1990; Sánchez-Gutiérrez, 2002; Santer, 2005; Caciotti, 2008; Davit-Spraul, 2008; Valadares, 2015). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024